Problem statement: Answer the MCQ question.
Query: Which drug exhibits a 5.730% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a: COc1ccccc1C(C)NC(=O)c1cc(=O)[nH]c2ccccc12
b: CCOC(=O)c1cc2c(=O)n3ccccc3nc2n(C)c1=NC(=O)c1c(-c2c(F)cccc2Cl)noc1C
c: Cc1nc(CNC(=O)c2cc(COc3c(F)cccc3F)on2)cs1
d: COc1cc(C)ccc1OCc1cc(C(=O)NCCN2CCOCC2)no1
e: Cc1sc2nc(CN3CCOCC3)nc(N3CCC(C(N)=O)CC3)c2c1C
Answer: e. Cc1sc2nc(CN3CCOCC3)nc(N3CCC(C(N)=O)CC3)c2c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1sc2nc(CN3CCOCC3)nc(N3CCC(C(N)=O)CC3)c2c1C
Cc1sc2nc(CN3CCOCC3)nc(N3CCC(C(N)=O)CC3)c2c1C
1-[5,6-dimethyl-2-(morpholin-4-ylmethyl)thieno[2,3-d]pyrimidin-4-yl]piperidine-4-carboxamide